Skip to main content
Log in

Vaccination against group A Streptococcus likely cost saving in the USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Andrejko K, et al. Health-economic value of vaccination against group A Streptococcus in the United States. Clinical Infectious Diseases : 30 Jun 2021. Available from: URL: http://doi.org/10.1093/cid/ciab597

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaccination against group A Streptococcus likely cost saving in the USA. PharmacoEcon Outcomes News 883, 29 (2021). https://doi.org/10.1007/s40274-021-7900-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7900-z

Navigation